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Abstract
A large body of evidence has appeared over the last 6 years suggesting that nitric oxide biosynthesis is a key factor in the
pathophysiological response of the brain to hypoxia-ischemia. Whilst studies on the influence of nitric oxide in this
phenomenon initially offered conflicting conclusions, the use of better biochemical tools, such as selective inhibition of nitric
oxide synthase (NOS) isoforms or transgenic animals, is progressively clarifying the precise role of nitric oxide in brain
ischemia. Brain ischemia triggers a cascade of events, possibly mediated by excitatory amino acids, yielding the activation of
the Ca2-dependent NOS isoforms, i.e. neuronal NOS (nNOS) and endothelial NOS (eNOS). However, whereas the selective
inhibition of nNOS is neuroprotective, selective inhibition of eNOS is neurotoxic. Furthermore, mainly in glial cells, delayed
ischemia or reperfusion after an ischemic episode induces the expression of Ca2-independent inducible NOS (iNOS), and its
selective inhibition is neuroprotective. In conclusion, it appears that activation of nNOS or induction of iNOS mediates
ischemic brain damage, possibly by mitochondrial dysfunction and energy depletion. However, there is a simultaneous
compensatory response through eNOS activation within the endothelium of blood vessels, which mediates vasodilation and
hence increases blood flow to the damaged brain area. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
It is well known that the brain is particularly sus-
ceptible to interferences with its blood supply [1].
Thus, in the absence of blood £ow, and therefore
of oxygen, the energy reserves of the brain are capa-
ble of sustaining ATP levels for about 1 min [2].
Since cerebral metabolism depends on a continuous
supply of glucose and oxygen, during an asphyctic
episode there is a compensative phenomenon aimed
at maintaining the brain circulation, and the body is
able to compensate for the hypoxemia without com-
promising vital organs. However, when the asphyxia
is prolonged, cerebral blood £ow (CBF) decreases
because of the fall in cardiac output, hence becoming
a critical factor in the appearance of brain damage
[3,4].
Although the pathophysiology of the above-men-
tioned phenomena has been extensively studied, over
the last 6 years, much evidence has suggested the
involvement of the free radical nitric oxide (cNO) in
control of the physiological responses to brain hypo-
xia-ischemia. In the present review, we discuss both
the neurotoxic and neuroprotective roles of cNO in
the ischemic phenomenon, with special emphasis on
the biochemical mechanisms through which cNO ex-
erts its interference.
2. Nitric oxide biosynthesis in the brain
It is now well established that cNO is a physiolog-
ical messenger in the central nervous system [5] (re-
viewed by [6]) and is synthesized by the cNO synthase
(NOS)-catalyzed reaction. Activation of this enzyme
forms cNO and L-citrulline from L-arginine [7,8], thus
participating in the transduction pathway leading to
elevations in intracellular cyclic GMP levels [9,10].
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Whilst the precise role of cNO production in the
brain remains to be fully elucidated, it seems that
this free radical is involved in important functions,
such as the regulation of the CBF or memory (for
reviews, see [11^13]). Thus, activation of NOS within
the endothelial cells produce cNO, which di¡uses to
the neighboring smooth muscle cells and activates
guanylate cyclase. The increase in cyclic GMP causes
smooth muscle relaxation and thus vasodilation [14].
Within the brain, the cerebellum is an important site
for cNO production after activation of NOS enzyme
[15] and all brain cells have now been shown to be
able to synthesize cNO (reviewed in [16,17]) following
di¡erent types of stimulus.
At least three isoforms of NOS have been charac-
terized in brain cells. Neurons produce cNO mainly
by Ca2-dependent activation of neuronal NOS
(nNOS or NOS1), which is constitutively expressed
in these cells [8]. In contrast, glial cells (astrocytes,
microglia and oligodendrocytes) synthesize cNO
mainly after calcium-independent inducible NOS ex-
pression (iNOS or NOS2) by treatment with the en-
dotoxin lipopolysaccharide (LPS) and/or certain cy-
tokines, such as interferon-Q, tumor necrosis factor-K
or interleukin-1L (for reviews, see [16^18]; see also
[19]). Finally, endothelial cells produce cNO by the
constitutive, Ca2-dependent activity of endothelial
NOS (eNOS or NOS3) [8]. In addition to this com-
monly accepted distribution, it should be mentioned
that most brain cell types are able to express several
NOS isoforms. Thus, astrocytes are known to pro-
duce cNO via the constitutive nNOS activity [20^23]
and both endothelial cells [24] and neurons [25] ex-
press iNOS after lipopolysaccharide plus cytokines
treatment.
3. Excess nitric oxide biosynthesis may be neurotoxic
Under certain pathological conditions, nNOS acti-
vation might be exacerbated and the excess cNO thus
formed becomes neurotoxic [26^28] and may play a
role in neurodegeneration (e.g. see the reviews [29^
32]). The mechanism leading to excessive nNOS ac-
tivation is thought to be mediated by the hyperacti-
vation of glutamate receptors, especially the N-meth-
yl-D-aspartate (NMDA) subtype, in the postsynaptic
neuron, which leads to increased intracellular free
Ca2, subsequent nNOS activation [28] and, possi-
bly, mitochondrial dysfunction and cell death [33].
In addition, several stimuli, most of them involving
cytokine-mediated gene expression activation,
strongly induce iNOS expression in glial cells, allow-
ing massive and uncontrolled cNO release by these
cells; this may be damaging for the neighboring neu-
rons [17,34].
The mechanism through which excess cNO forma-
tion within the brain leads to neuronal death in-
volves energy depletion, lipid and protein peroxida-
tion, protein nitrosylation and DNA damage
(reviewed in [32]). Furthermore, whereas the cNO
species has been shown to cause some cell damage
in vitro, increasing evidence suggests that the endog-
enous formation of peroxynitrite anion (ONOO3),
from the reaction of cNO with Oc32 [35,36], may be
a possible mechanism through which neurotoxicity is
induced. The relevance of these mechanisms for cNO-
mediated brain damage in hypoxia-ischemia will be
discussed below.
4. Nitric oxide biosynthesis is increased by ischemia
4.1. Neuronal production of cNO in ischemia
Despite the evidence suggesting excessive cNO bio-
synthesis due to ischemic injury, direct experimental
evidence showing enhanced cNO biosynthesis in the
brain in vivo has emerged from electron paramag-
netic resonance (EPR) spectroscopy with spin-trap-
ping agents after freezing tissue samples from bilat-
eral carotid occlusion or focal ischemia of the rat
brain. The signal increased according to the degree
of the ischemic insult [37,38] and during reperfusion
if ischemia was greater than 15 min [39] and disap-
peared following administration of the NOS inhibi-
tor L-Ng-nitro-L-arginine methyl esther (L-NAME)
[40]. Other studies have subsequently con¢rmed and
expanded the notion that brain cNO biosynthesis is
increased by ischemic insult. With the EPR spectros-
copy technique, nitrosyl hemoglobin due to the is-
chemic episode has been only weakly detected, but is
strongly detected after reperfusion [41], suggesting
that oxygen recovery enhances cNO synthesis. In in
situ imaging of the EPR signal, cNO has been selec-
tively detected in certain brain areas, such as the
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cortex, hippocampus, hypothalamus, amygdala and
substantia nigra during ischemic episodes [42,43]. In
a study using a cNO microsensor, the ischemia pro-
duced by middle cerebral artery (MCA) occlusion
increased L-NAME-inhibitable cNO concentrations
in the ischemic tissue [44], pointing to a correlation
between the degree of hippocampal CA1 sector in-
jury and cNO [45]. Other indirect methods have also
provided evidence for cNO production within the is-
chemic brain, such as increased concentrations of the
cNO-decomposition product nitrite (NO32 ) in dialy-
sates from in vivo microdialysis in the striatum after
common carotid artery occlusion [46]. In a rat MCA
occlusion model, NO32 and cyclic GMP levels in-
creased sharply after 20 min of ischemia, but NO32
levels returned to basal values after 60 min, a pattern
that correlated well with the 10-fold increase in NOS
activity [47]. Finally, an L-NAME-inhibitable in-
crease in cyclic GMP has also been observed in the
hypoxemic rabbit [48].
Increased expression of nNOS mRNA in ischemic
lesions has also been detected in the rat as early as
15 min after MCA occlusion [49] or after prolonged
hypoxia [50], although in the latter study, eNOS
mRNA expression decreased and GTP-cyclohydro-
lase-I mRNA expression (the rate-limiting step in
the biosynthesis of tetrahydrobiopterin, a NOS co-
factor) increased. Importantly, the nNOS mRNA-
containing neurons remained undamaged [49], sug-
gesting that cNO-releasing neurons are resistant to
ischemic injury. Similar results were found using
nNOS antibodies in 7-day-old rats subjected to
24 h of hypoxia, where the number of nNOS-pos-
itive neurons close to the neuronal injury degener-
ation area increased as from early stages of the
hypoxic episode [51], strongly suggesting a possible
role of cNO in the accompanying neurodegenera-
tion.
Finally, NOS activity has been measured in the
brain of animals subjected to hypoxia and reoxyge-
nation. In piglets, cytosolic NOS activity decreased
during hypoxia [52,53], but increased after reoxyge-
nation [53]. Similarly, after 2 h of focal ischemia in
mice followed by recirculation, there was a rapid
decrease in constitutive NOS activity in the infarcted
cortex, but an increase in Ca2-independent NOS
activity (re£ecting iNOS) and the NO32 concentration
was observed during reperfusion [54]. In another
study, increased nNOS-immunopositive neurons
were observed after 37 days of hypoxia in the CA3,
but not the CA1 hippocampal region of the rat
brain, and low doses of the NOS inhibitor Ng-ni-
tro-L-arginine (L-NNA) decreased the number of
damaged neurons [55]. However, no iNOS protein
was detected in this study.
4.2. Glial production of cNO in ischemia
Although some studies have failed to show in-
creased Ca2-independent NOS activity in the rat
MCA occlusion model [56], substantial evidence
now strongly suggests that glial cells may be impor-
tant sites for cNO production in ischemia. Thus,
transient global ischemia causes an early expression
of NADPH-diaphorase activity [57,58] and iNOS im-
munoreactivity [59] in reactive astrocytes (but not
microglia), which in turn may release toxic amounts
of cNO and, possibly, cause neuronal damage. In
vitro models of hypoxia-ischemia have also revealed
the expression of iNOS mRNA, protein expression
and enzyme activity in cultured glial cells [60] and in
brain slices [61]. Interestingly, in the latter study,
iNOS protein was immunohistochemically localized
not only in astrocytes, but also in neurons and mi-
croglial cells [61]. There is now a strong body of
evidence suggestive of iNOS overexpression in glial
cells in vivo due to ischemic insults. Thus, in the rat
MCA occlusion model, Iadecola and co-workers re-
ported increases in Ca2-independent activity accom-
panied by glial ¢brillary acidic protein (GFAP)-pos-
itive cells in the infarcted areas [62,63]. Moreover,
cerebral damage was prevented by the selective
iNOS inhibitor aminoguanidine [64,65], strongly sug-
gesting a role for glial-derived cNO in ischemic dam-
age. Similar results have been observed using histo-
chemically detected NADPH-diphorase activity and
GFAP antibody [66]. Finally, in a study of the re-
gional distribution and levels of NOS protein in the
brain of stroke-prone spontaneously hypertensive
rats, considerable NOS immunoreactivity was found
in reactive astrocytes and microglial cells in the vi-
cinity of the lesions [67], suggesting that the cNO
generated by glial cells might contribute to the devel-
opment of hypertensive cerebral lesions.
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4.3. cNO production by brain endothelial cells in
ischemia
Brain endothelial cells have also been shown to
increase cNO production in ischemia. In the rat
MCA occlusion model, eNOS has been detected im-
munohistochemically in cerebral vessels in the ische-
mic region [68]. In cerebral vessels, a 3^7-fold in-
crease in Ca2-dependent NOS activity was
observed after 2^7 days of ischemia in the same mod-
el, although Ca2-independent NOS activity was also
present after the ¢rst day of ischemia [69]. However,
in a study carried out in the monkey subarachnoid
hemorrhage model, while eNOS mRNA expression
was seen to be decreased in cerebral arteries, it in-
creased in neural tissue [70]. The authors suggest that
the decrease in arterial eNOS might be responsible
for the vasospasm while increased neural eNOS
might be a compensatory mechanism against ische-
mia. Despite the latter work, most studies have sug-
gested increased eNOS activity during ischemia.
Thus, in rats [71] or in piglets [72], transient global
cerebral ischemia is accompanied by enhanced eNOS
immunoreactivity in the blood vessels of the hippo-
campus and it has been suggested that the cNO pro-
duced by this mechanism may have neuroprotective
e¡ects due to a possible improvement in CBF (see
below). Finally, the presence of in vivo induction of
iNOS in vascular cells has also been observed in the
rat MCA occlusion model [73]. In this study, iNOS
mRNA expression and protein immunohistochemical
localization were maximal after 12 h of ischemia, but
immunoreactivity was restricted to the walls of capil-
laries and larger blood vessels after 12^24 h [73].
5. Neurotoxic versus neuroprotective roles of nitric
oxide synthesis in ischemia
Early studies carried out to elucidate whether cNO
protects or damages the brain during ischemia
yielded con£icting conclusions (e.g. see [74^78] versus
[79^81]). Although this discrepancy could be attrib-
uted to di¡erences in the experimental animal species
used [82], the use of selective NOS inhibitors or
transgenic animals now suggests that in fact cNO
can be either neuroprotective or neurotoxic, depend-
ing on the cell type from which it is released (neuro-
nal, glial or endothelial) and the length and severity
of the ischemic insult (see Fig. 1). This issue has
recently been reviewed [83^86].
5.1. Neurotoxicity of cNO in brain ischemia
Through measurements of the volume of the in-
farcted area after cerebral ischemia, many studies
have demonstrated the protective e¡ect of NOS in-
hibitors. Thus, L-NNA or L-NAME protected
against cerebral damage in rats [87^96], cats [97]
and gerbils [98,99] subjected to MCA occlusion.
Although some studies have failed to demonstrate
Fig. 1. Neuroprotective versus neurotoxic e¡ects of nitric oxide
in hypoxia-ischemia. Both neuroprotective and neurotoxic ef-
fects have been reported when NOS inhibitors are used during
brain hypoxia-ischemia. A possible explanation for these con-
£icting hypotheses is that, whilst ischemic-mediated activation
of nNOS in neurons leads to neuronal cell death, activation of
eNOS in endothelial cells is neuroprotective. Neuroprotection
may occur because the cNO formed in endothelial cells pro-
duces relaxation in adjacent smooth muscle cells, thus leading
to vasodilation and increased cerebral blood £ow to the ische-
mic brain region. In addition, induction of iNOS expression in
astrocytes occurs after ischemic episodes. The precise conse-
quences of the latter phenomenon are not known, but it has
been suggested that the excess cNO formed by this way may be
both neurotoxic and neuroprotective. Thus, astrocyte-derived
cNO may be neurotoxic because it interferes in neuronal energy
metabolism as described in Fig. 2, but it may also be neuropro-
tective because it may produce relaxation in neighboring
smooth muscle cells.
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improvements in CBF distribution due to NOS in-
hibitors [89,97,100], other groups have reported in-
creases in CBF [101,102]. The most susceptible brain
region to ischemic-mediated cNO injury seems to be
the CA1 area of the hippocampus, possibly because
it receives a large vascularization, where L-NNA ex-
erts maximal protection [98,103,104]. Within this re-
gion, a selective loss of NADPH diaphorase-contain-
ing neurons occurs [105], in contrast to the idea of
NOS-positive neurons being less vulnerable to cNO-
mediated injury [27].
There seems to be a time-dependent neuroprotec-
tion of NOS inhibitors against ischemic damage.
Thus, in a rat model of focal ischemia, L-NAME
exerted better protection during the early stages of
the ischemic insult [106]. By contrast, other authors
have reported protection by NOS inhibitors during
postischemic episodes [102]. In this context, choice of
the NOS inhibitor seems to be relevant in preventing
cNO-mediated ischemic injury. Thus, the selective in
vivo nNOS inhibitor 7-nitroindazole (7-NI), but not
the unselective L-NNA, was protective against cere-
bral infarction in the MCA or bilateral occlusion
models [107,108]. Furthermore, prehypoxic treatment
with 7-NI prevented cNO production during hypoxia
and reoxygenation, but aminoguanidine (selective
iNOS inhibitor) only prevented cNO production dur-
ing re-oxygenation [109,110]. These results strongly
suggest di¡erent roles for constitutive and inducible
nitric oxide synthases in the development of ischemic
brain damage. Neuronal production of cNO seems to
occur during the early ischemic period, which is fol-
lowed by delayed glial cNO production.
5.2. Glial cells in ischemic-mediated cNO
neurotoxicity
A phenomenon observed after brain ischemia is
the appearance of reactive astrocytes [111], as meas-
ured by the increased number of GFAP-reactive cells
and the increase in local cerebral glucose utilization
[112]. A population of these GFAP-positive cells,
formed by astrocytes, but not by microglial cells
[58], also expresses iNOS [57,59]. Interestingly,
spreading depression, which confers increased neuro-
nal susceptibility to ischemic damage, induces nNOS
(neuronal) protein expression in astrocytic cells [113],
supporting a potential role for glial cells in ischemic
neurotoxicity. However, the exact mechanism of this
ischemic-mediated astrocyte activation is not well
understood. Whereas iNOS induction in astrocytes
has been purported to be a consequence of ische-
mic-mediated neuronal damage [58], it has also
been suggested that neuronal damage after hypoxia/
ischemia episodes may be due to excessive cNO for-
mation by reactive astrocytes [57,59]. Therefore,
whether the induction of iNOS in glial cells is a con-
sequence or a cause of the neuronal degeneration
observed after ischemia remains to be discovered.
5.3. Brain ischemia, cNO and immunity
Although there is evidence suggesting a role for
cytokines and growth factors as mediators of ische-
mic-mediated iNOS induction in glial cells and neu-
rotoxicity [114,115], increasing evidence now suggests
that the cytokines and growth factors released by
glial cells might be neuroprotective against brain is-
chemia [116,117]. In this sense, in cultured rat astro-
cytes, hypoxic episodes followed by re-oxygenation
increased the release of interleukin-1 [118]. Further-
more, basic ¢broblast growth factor, epidermal
growth factor or insulin-like growth factor in vitro
[119,120], and glial-derived neurotrophic factor in
vivo [121] and pretreatment of transforming growth
factor-L1 before an ischemic insult in vivo [122] have
all been shown to prevent hippocampal neurons
against cNO neurotoxicity. The role of ischemic-
mediated iNOS induction in glial cells has been re-
viewed elsewhere [123^126].
5.4. Neuroprotection by cNO in brain ischemia
In several models of brain ischemia, several studies
have reported results apparently in contradiction
with the generalized notion of a neurotoxic role for
ischemic generated cNO. These include the work car-
ried out in gerbils [127,128] and in rats [79,81,129]
showing an enhancement of the infarcted area
through the inhibition of NOS activity by L-NNA
or L-NAME. In experiments in which cerebral blood
volume and the infarcted region were monitored
[130], it was reported that NOS inhibition prevents
the vasodilation caused by ischemia, suggesting that
increased cNO production during ischemia would be
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protective because it modulates the CBF. Now, much
evidence strongly suggests that the control of CBF
by excess release of cNO during, and especially after,
ischemic episodes may have a bene¢cial role.
5.5. Endothelial cells in ischemic-mediated cNO
neuroprotection
The protective role of cNO during ischemia may be
due to the vasodilation (due to the cNO-mediated
raise in cyclic GMP) and by the cNO-mediated inhi-
bition of microvascular plugging by platelets and
leukocytes, hence causing the increase in CBF by
this free radical [14,131]. In fact, administration of
cNO donors to ischemic MCA-occluded rats im-
proved CBF and reduced ischemic-mediated cerebral
infarction [132^135]. This is supported by the obser-
vation that infusion of L-arginine (the substrate for
cNO biosynthesis) increases regional CBF, preventing
both necrotic damage in the rat MCA occlusion
model [136,137] and decreases in brain ATP and glu-
cose levels in the spontaneously hypertensive rat
[138].
Interestingly, in gerbil the degree of NOS inhibi-
tion seems to play an important role in modulating
ischemic-mediated brain damage [139]. In this study,
low doses of L-NNA administration prevented, and
high doses potentiated, ischemic-mediated neuronal
degeneration [139], suggesting that during ischemia
a small amount of cNO is bene¢cial to brain tissue,
whereas an excessive amount of cNO causes neuro-
toxic e¡ects. Further evidence has suggested that
both the neuroprotective and neurotoxic e¡ects of
cNO during ischemia could be due to the di¡erent
source of cNO under these circumstances. In a recent
study [140], postischemic cNO concentrations were
manipulated by using combinations of both L-
NAME (an unselective NOS inhibitor) and 7-NI (a
selective nNOS inhibitor) in experimentally induced
thromboembolic stroke in the rat. It was observed
that 7-NI protected against and L-NAME potenti-
ated hippocampal neuronal injury, suggesting that
while enhanced nNOS activity during ischemia is
neurotoxic, the increase in endothelial eNOS activity
would be bene¢cial [140]. In the same ischemic mod-
el, L-NAME protected against platelet accumulation
and hemodynamic depression [141], suggesting that
these phenomena may account for the cognitive and
sensory-motor de¢cits observed in this animal model.
Finally, in the MCA occlusion model, NOS inhibi-
tion with L-arginine analogs potentiated cerebral in-
farction due to ischemia in the rat [142], piglet [143],
lamb fetus [144], cat [145] and dog [146]. However,
this potentiation was prevented by the infusion of
either L-arginine or the nNOS inhibitor 7-NI [142].
Furthermore, L-arginine administration [142] or he-
moglobin removal by £uorocarbon administration in
the perfusates [147] produces vasodilation, leading to
increased CBF and an improvement in electrocorti-
cogram activity. These results support the notion
that during ischemia, neuronal-derived cNO is neuro-
toxic, whereas endothelial-derived cNO is bene¢cial,
due to the increase in CBF and, therefore, in the
oxygen and substrate supply to the insulted brain
area.
Whether the vasodilator e¡ects of endothelial-de-
rived cNO in brain ischemia are mediated by cyclic
GMP is not known, although early in vivo evidence
has suggested that this would be the case [148]. In a
recent study of an in vitro model of the blood^brain
barrier, Oc32 scavenging proved to be protective after
a hypoxic insult [149], which suggests that Oc32 might
be neurotoxic because it reacts with cNO to form
ONOO3. Nevertheless, the hypothesis that cNO
would regulate CBF during anoxia has been ques-
tioned since it has been reported that acetylcholine-
mediated cNO enhancement in a reptile and in a tele-
ost increases CBF by a L-NAME-inhibitable process.
However, anoxic-induced CBF enhancement could
not be blocked by L-NAME [150,151]. The length
of the ischemic insult appears to determine the de-
gree of contribution of cNO to cerebral damage,
although the results obtained so far are controversial
[152,153].
Hypercapnia is thought to mediate vasodilation,
although the precise mechanism of this is still un-
known. Initial studies a¡orded contradictory results
about the involvement of cNO in hypercapnic-medi-
ated vasodilation. Thus, whereas in an MCA occlu-
sion model in the goat L-NAME did not prevent
hypercapnic-mediated vasodilation [154], in a similar
model, the same compound prevented vasodilation
due to hypercapnia, but not to hypoxia [155,156].
Moreover, the L-NAME-mediated attenuation of
CO2-induced vasodilation could be reversed by either
a cNO donor (SIN-1, 3-morpholinosydnonimine) or
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the cyclic GMP analog 8-bromo-cyclic GMP [157],
strongly supporting the notion that a certain level of
cNO is essential for the maintenance of the smooth
muscle relaxation necessary for vasodilation during
hypercapnia.
5.6. Hypothermia and cNO-mediated neuroprotection
in ischemia
Many studies now suggest that mild hypothermia
is neuroprotective against cerebral ischemic damage.
Furthermore, it appears that the protective role of
hypothermia might be related to its capacity to pre-
vent elevations in cNO levels [158,159] and neuronal
degeneration [160^162]. The precise mechanism of
this neuroprotective role still needs clari¢cation, but
it should be mentioned that a potential role for glial
cells has been reported. In this sense, hypothermic-
mediated suppression of microglial activation has
been observed [163], possibly suggesting that inhibi-
tion of glial-derived cNO by cold treatment would be
bene¢cial for the ischemic brain.
5.7. Brain ischemia, cNO and acidosis
Inhibition of NOS activity prevents the decrease in
intracellular pH in a brain focal ischemia model in
rabbits [164,165], suggesting a cNO-mediated process
in the phenomenon of ischemic acidosis.
5.8. Studies in transgenic animals
The development of transgenic animals has o¡ered
a powerful tool for the study of the consequences of
cerebral ischemia. Mice lacking all known isoforms
of cNO synthases have now been used to study the
e¡ects of cerebral ischemia. It has been shown that
nNOS-de¢cient mice are less vulnerable to hippo-
campal neuronal damage (usually measured as the
volume of infarcted area) after transient or perma-
nent ischemia in the MCA occlusion model [166^
170]. Interestingly, eNOS-transgenic mice are highly
vulnerable to cerebral ischemia [171]. These works
support the notion that while neuronal-derived cNO
during ischemia is neurotoxic, endothelial-derived
cNO is neuroprotective, possibly because of the im-
provement in CBF. Finally, the null mutation of the
iNOS gene in mice prevents delayed neurotoxicity
caused by brain ischemia [172], in agreement with
the idea that delayed cNO release by ischemic-medi-
ated induction of iNOS expression might be respon-
sible for the toxicity of prolonged ischemia.
Other reports have used mutations in superoxide
dismutase (SOD)-encoding genes, allowing study of
the Oc32 radical in ischemic brain injury. Thus, Cu/
Zn^SOD-overexpressing transgenic mice show in-
creased brain injury after perinatal hypoxia-ischemia
[173]. Since the overexpression of SOD might in-
crease H2O2 and/or cNO accumulation, the results
suggest an involvement of these compounds in the
mechanism of neurotoxicity. On the other hand,
Mn^SOD-de¢cient transgenic mice are more suscep-
tible to cerebral damage [174]. The exact role of SOD
in ischemic brain damage therefore remains obscure
(see review [175]).
5.9. cNO and memory in the ischemic brain
So far, reports about the role of cNO generated
during brain ischemia in memory loss have been con-
tradictory. In an in vivo rat model aimed at quanti-
fying the number of errors committed in a working
memory task, inhibition of NOS activity by L-
NAME by intrahippocampal administration pre-
vented the increase in errors caused by 5 min of
ischemia [176]. This suggests a role for cNO in mem-
ory loss after ischemia. In contrast, in vitro, speci¢c
nNOS inhibitors (7-NI) prevented the long-term po-
tentiation caused by anoxia in CA1 hippocampal
neurons [177]. Although other mechanisms can be
involved in cNO-dependent anoxic-induced potentia-
tion not linked with memory processes, further re-
search in this ¢eld would evidently be appropriate in
order to fully clarify the precise role of cNO in mem-
ory loss after anoxia.
6. The role of nitric oxide and excitatory amino acids
in the ischemic brain
It is well known that brain hypoxia-ischemia leads
to an increase in the extracellular concentration of
glutamate [178,179] and that excitatory amino acids,
such as glutamate, induce degenerative changes in
nervous tissues that mimic those produced by hypo-
xia [180,181]. In addition, enhanced nNOS gene ex-
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pression may be achieved by ischemia through a
mechanism involving NMDA-receptor activation
[182], although the precise relevance of this observa-
tion remains to be elucidated. Furthermore, NMDA
glutamate subtype receptor antagonists protect neu-
rons from hypoxia-mediated neurotoxicity [183,184].
Since cNO at least partially mediates NMDA-de-
pendent neurotoxicity [26], the role of cNO in
NMDA-mediated ischemic brain injury has been ad-
vanced (reviewed in [30,31]). However, this remains
controversial, as discussed below. Early studies dis-
closed in vivo protection by the NMDA-receptor
antagonist MK-801 in brain infarction after MCA
occlusion ischemia in the mouse [74] and suggested
the involvement of neuronal cNO in the process. In
vitro work has shown that CA1 hippocampal neu-
rons are particularly susceptible to cNO-mediated is-
chemic damage through a process mediated by excess
glutamate receptor activation [185]. Hypoxic/ische-
mic-mediated glutamate^cNO toxicity is potentiated
by glucose depletion [186] or by neuronal exposure
to astrocyte-derived cNO [187], suggesting that neu-
ronal de-energization increases susceptibility to
NMDA-mediated ischemic damage. This is in agree-
ment with the hypothesis that early anoxic depolari-
zation leading to the release of Ca2 from intracel-
lular stores might be responsible for subsequent
nNOS activation and toxicity [188,189], although
further experiments aimed to fully clarifying the pre-
cise mechanism of nNOS activation in ischemia are
warranted.
Despite the above-mentioned evidence, a number
of studies have failed to show the potential role of
cNO in NMDA neurotoxicity [190^193] or in
NMDA-mediated ischemic neurotoxicity [194^196].
Whether this discrepancy can be attributed to the
redox cell status and hence NMDA receptor activity
modulation [197] remains to be established. Never-
theless, the involvement of cNO in glutamate release
by brain cells exposed to ischemic injury has been
disregarded [198^200], and a role for adenosine re-
ceptor activation in astrocytes may reproduce the
neurotoxic e¡ects of ischemia by an cNO-mediated
mechanism not involving neuronal glutamate recep-
tors in hippocampal slices [201]. It appears that me-
tabotropic, rather than ionotropic, glutamate-recep-
tor subtype activation leading to cNO production in
ischemia may be responsible for this neuroprotective
role [202]. Surprisingly, more and more evidence is
now suggesting that NMDA-receptor activation
leading to cNO production during ischemia may
also be neuroprotective. Thus, the cNO formed in
neurons by NMDA activation reaches neighboring
arterioles, where it elevates cyclic GMP, hence pro-
ducing vasodilation, possibly mediated by opioids
[203], and improving regional CBF [204^206].
7. Peroxynitrite and brain ischemic damage
The scavenging of oxygen-derived free radicals
prevents neurotoxicity due to the excess cNO formed
during ischemia [207,208] and during NMDA recep-
tor activation [209^211]. These observations strongly
suggest the involvement of endogenous peroxynitrite
(ONOO3) formation, leading to neuronal degenera-
tion after ischemic, glutamate-mediated activation of
nNOS [77,212,213]. The in situ production of
ONOO3 has been detected by chemical [214] and
immunohistochemical [215] determinations of 3-ni-
trotyrosine, a compound thought to be speci¢cally
accumulated by the action of ONOO3. Since
ONOO3 is a strong pro-oxidant compound [35,36],
lipid peroxidation is another possible feature of en-
dogenous ONOO3 formation. In this sense, brain
lipid peroxidation and membrane dysfunction have
been observed in in vivo hypoxia, pointing to
ONOO3 as the origin of such e¡ects [216^218]. Fi-
nally, SOD-overexpressing transgenic mice are highly
resistant to ischemic brain damage [219] and display
strongly suppressed ONOO3 production, lipid per-
oxidation, and considerable mitochondrial dysfunc-
tion [220], suggesting a potential role for ONOO3 in
cNO-mediated ischemic brain injury.
8. Mechanisms for nitric oxide-mediated brain
damage
The most widely accepted ischemic perturbation
that culminates in brain damage is the uncoupling
of oxidative phosphorylation [221]. This phenomen-
on is characterized by the inability of mitochondria
to generate energy in the form of ATP. Instead, any
energy that is produced by the mitochondrial respi-
ratory chain is dissipated as heat [222]. The observa-
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tion that an increased cerebral metabolic rate for
glucose runs concomitant with decreased cerebral en-
ergy utilization has con¢rmed that the decrease in
ATP concentrations occurring during the recovery
phase is due to the uncoupling of mitochondrial ox-
idative phosphorylation (Fig. 2) [223^225].
8.1. Mitochondrial dysfunction and cNO in brain
ischemic damage
The precise mechanism responsible for mitochon-
drial dysfunction due to hypoxia-ischemia in the
brain is not fully understood. Initial evidence came
from studies suggesting that a loss of respiratory
control [226,227], a decline in ATP synthesis, and
mitochondrial swelling and enhanced lipolysis of mi-
tochondrial membranes occur in these circumstances
[228,229]. Mitochondrial respiration and the mito-
chondrial respiratory chain seem to be especially sus-
ceptible to hypoxia-ischemia and reperfusion. Thus,
during brain ischemia complexes I and II^III of the
mitochondrial respiratory chain are damaged in both
the rat [230] and the gerbil [231]. However, although
the activity of complex IV is not a¡ected by ischemia
[231,232], it is strongly inhibited after a long period
(120 min) of reperfusion [232,233], suggesting irre-
versible damage to this complex, possibly due to
free radical production and lipid peroxidation. Inter-
estingly, complex IV activity, together with that of
complex II^III are the most susceptible components
of the mitochondrial respiratory chain to irreversible
damage due to excess cNO production in brain cells
[33,234] (for a review, see [32]). Moreover, the brain
activity of these complexes is severely damaged in the
brain of neonates subjected to 5 min of anoxia. How-
ever, inhibition of brain NOS activity by L-NAME
administration to the mothers prevented this mito-
chondrial damage [235], strongly suggesting that mi-
tochondrial dysfunction during brain ischemia may
be a cNO-mediated process.
8.2. cNO-mediated poly(ADP-ribose) synthesase
activation in brain ischemia
Brain ischemic damage is prevented by inhibitors
of poly(ADP-ribose) synthesase [236] and in trans-
genic mice lacking poly(ADP-ribose) polymerase
[237]. Since the increase in the activity of this en-
ergy-consuming pathway is believed to mediate
cNO neurotoxicity [238], this mechanism may con-
tribute to cNO-mediated cerebral damage during is-
chemia.
9. Hypoxia-ischemia and nitric oxide during the
perinatal period
During pregnancy, cNO biosynthesis increases in
Fig. 2. Neurotoxicity of nitric oxide during hypoxia-ischemia
and reperfusion. Decreased oxygen availability within the neu-
ron during an hypoxic-ischemic episode may reduce the mito-
chondrial ATP production. Transient ATP depletion prevents
the Ca2 pumping from the cytosol into organelles, such as the
endoplasmic reticulum. Therefore, increases in cytosolic Ca2
activate the constitutive Ca2-dependent nNOS. However, since
nNOS activity depends on O2 availability, it is not maximal un-
til O2 is present in considerable amounts. This may be achieved
during a mild hypoxic episode or during the reoxygenation peri-
od after transient ischemia. Thus, during reoxygenation, the O2
concentration increases sharply and nNOS therefore becomes
fully activated. In addition, rapid O2 availability may exceed
the mitochondrial capacity to reduce O2 to H2O and hence
superoxide anion (Oc32 ) production may be enhanced. If this is
the case, Oc32 avidly reacts with
cNO to form peroxynitrite
(ONOO3), which is a well-known irreversible inhibitor of mito-
chondrial function and a pro-oxidant compound that damages
lipids, proteins and DNA, leading to neuronal cell death.
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rats [239] and humans [240], possibly contributing to
maternal vasodilation and uterine immune suppres-
sion during this period. The rat placenta is another
site of cNO biosynthesis because both constitutive
and inducible NOS occur in this tissue [239^241].
However, the pathophysiological relevance of this
observation remains to be determined. Despite this,
a potential role for cNO in brain development has
been advanced. Thus, in the embryonic central nerv-
ous system, nNOS would be expressed transiently in
neurons [242,243] and in brain blood vessels [244],
and would normally precede synaptogenesis, suggest-
ing that cNO would mediate the formation of synap-
tic connections during development [245]. Interest-
ingly, there seems to be a di¡erent pattern in brain
NOS expression between precocious and non-preco-
cious species. Regarding this issue, in the rat (a non-
precocious species), brain NOS activity mainly devel-
ops postnatally [246], reaching adult levels at about
2 weeks after birth and rising to 150 or 130% of
adult activity in the forebrain and cerebellum, respec-
tively [247]. However, in the guinea pig (a precocious
species), brain NOS activity (predominantly Ca2-de-
pendent) reaches adult levels before birth [247]. In
both species, the increase in brain NOS activity im-
mediately precedes synaptogenesis and seems to be
mediated by estrogens [247]. Therefore, NOS activity
develops according to the pattern of brain matura-
tion, suggesting an important role for cNO in brain
development and function.
9.1. cNO mediates brain damage in perinatal asphyxia
Regardless of the potentially relevant role of cNO
in normal physiological brain development and func-
tion, a number of studies have linked excessive bio-
synthesis of this free radical to perinatal hypoxic-is-
chemic neurodegeneration. In this context, inhibiting
NOS in vivo in 7-day-old rats protects them against
hypoxic-ischemic-mediated neurotoxicity [91,93,248];
the number of nNOS-containing neurons increases in
the early phase of neonatal rat hypoxic-ischemic
brain injury [51] and treatment with quisqualate,
which selectively destroys nNOS-containing neurons,
protects neonatal rats against hypoxia-ischemia
[249]. Furthermore, brain mitochondrial damage
during early neonatal anoxia is prevented by L-
NAME treatment of the mothers [235]. Despite this
evidence, con£icting hypotheses have also been sug-
gested. For instance, synaptosomes isolated from
neonatal rat brain did not show altered cNO synthe-
sis or antioxidant status after in vitro hypoxia [250].
Likewise, it has been observed that neither cytosolic
nor membrane bound NOS activity are a¡ected in
cortical tissue in an in vivo model of hypoxia in
the newborn piglet [52]. Whether increased oxidative
stress and decreased antioxidant status [216] play
relevant roles in cNO-mediated brain damage after
hypoxic-ischemic insult during the perinatal period
remains to be elucidated.
9.2. Excitotoxicity and perinatal ischemic brain
damage
The immature brain is particularly susceptible to
excessive release of the excitatory amino acids gluta-
mate and aspartate [251]. In fact, the proportion of
the glutamate-receptor subtype, NMDA, in both the
immature rat brain cortex and the developing human
brain is much greater than that observed in the adult
brains of the same species [252]. Activation of this
receptor is considered to be an important feature in
the development of postischemic neuronal injury be-
cause the use of NMDA antagonists, such as MK-
801, elicits neuroprotective e¡ects under a variety of
experimental conditions [195,253^257]. Furthermore,
the extracellular levels of excitatory amino acids in-
crease several-fold during asphyctic insult to the cer-
ebral cortex and striatum of fetal sheep [258] and to
the cerebral cortex of the neonatal rat [259], support-
ing the notion of increased perinatal vulnerability to
excitatory amino acids.
Glutamate-receptor activation caused by presyn-
aptic release of this excitatory amino acid after peri-
natal hypoxia-ischemia may initiate a cascade of bio-
chemical e¡ects leading to neurotoxicity [260]. One
possibility may involve nNOS activation and there-
fore cNO-mediated neuronal degeneration, as men-
tioned above. However, little is known about the
exact mechanism of this toxicity. The production of
cytokines, especially interleukin-1L, by the perinatal
brain after NMDA injection has recently been sug-
gested [261]. In fact, interleukin-1L mRNA expres-
sion increases transiently after ischemic, traumatic
and excitotoxic brain injury [262^264]. Further ex-
periments are necessary to fully establish whether
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enhancement of this cytokine has a neurotoxic or a
neuroprotective role.
10. Therapeutic strategies
The expression of a novel endogenous NOS pro-
tein inhibitor induced by brain ischemia that partic-
ipates in the prevention of CA1 hippocampal neuro-
degeneration [265] strongly supports the notion that
NOS inhibitors, especially nNOS inhibitors, might
o¡er a bene¢cial therapeutic strategy. Thus, several
novel nNOS inhibitors have now been shown to pre-
vent brain damage during ischemia, such as tirilazad
[266,267], N-(S-methylisothioureido)-L-norvaline (L-
MIN) [268] or ARL-17477 [269]. The inhibitor of
glutamate release lubeluzole [270], glutamate antag-
onists, such as lamotrigine [271], antioxidants such as
LY231617 [272], a novel receptor ligand JO1784
[273], immunosuppressants, such as FK506
[274,275], melatonin as a cNO and other free-radical
scavenger [276] or a long-acting SOD derivative com-
pound which increases cNO availability and improves
cerebral blood blow [277] all potentially o¡er novel
therapeutic strategies which should be taken into ac-
count in circumstances of brain hypoxic-ischemic
neurodegeneration.
11. Concluding remarks
The increased cNO biosynthesis observed in the
brain during hypoxic-ischemic insult seems to be a
physiological response aimed at compensating the
de¢ciency in oxygen and substrate for neural cells.
Thus, endothelium-derived cNO produces smooth
muscle relaxation and therefore vasodilation of the
brain vessels, resulting in increased CBF to the in-
farcted brain area. Despite this mechanism, however,
neuronally derived cNO during ischemia, possibly
due to excitatory amino acid-mediated nNOS activa-
tion, may at the same time be neurotoxic, possibly
because of the interference of cNO and/or ONOO3
with energy metabolism, especially the mitochondrial
respiratory chain and activation of energy-consum-
ing DNA-repair pathways. The pathophysiological
role of the delayed increase in iNOS expression ob-
served in glial cells exposed to hypoxic-ischemic in-
sult is still unclear. Whilst cytokines, which are able
to induce iNOS expression, have been shown to be
neuroprotective, recent evidence strongly suggests
that iNOS expression in glial cells might be respon-
sible for the toxicity observed after prolonged ische-
mia. Further work seems necessary to fully dissect
the precise e¡ects of cNO, that depend on the time,
sources and targets of cNO delivered during brain
hypoxic-ischemic insult. Finally, selective nNOS in-
hibitors, which do not compromise endothelium-
mediated vasodilation, may o¡er a potential thera-
peutic strategy to prevent ischemic brain damage,
although this is still a novel ¢eld and requires further
study.
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